Drug Pipeline

Glycerol Phenylbutyrate 1100 MG/ML [Ravicti] Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
2
Recruiting
4
Top Sponsors
Active Studies by Phase
Phase 2
2
Early Phase 1
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06887777 Efficacy and Safety of the Treatment of Pyruvate Dehydrogenase Deficiency Patients With… Pyruvate Dehydrogenase Complex Deficiency Disease Recruiting
NCT05983588 PROFIL Study to Investigate the Effect of GPB on NfL Levels in Patients With Corticobasal… Corticobasal Syndrome (CBS) Active, Not Recruiting
Early Phase 1
NCT04937062 Phenylbutyrate for Monogenetic Developmental and Epileptic Encephalopathy STXBP1 Encephalopathy With Epilepsy, SLC6A1 Neurodevelopmental Disorder Active, Not Recruiting
Not specified
NCT06904027 A Clinical Study of Glycerol Phenylbutyrate in Chinese Patients With Urea Cycle Disorders Urea Cycle Disorders Recruiting
Sponsors Running Glycerol Phenylbutyrate 1100 MG/ML [Ravicti] Trials
Weill Medical College of Cornell University (1) Technical University of Munich (1) Assistance Publique - Hôpitaux de Paris (1) Tongji Hospital (1)
Disease Areas
Epilepsy (1)
Get alerts when Glycerol Phenylbutyrate 1100 MG/ML [Ravicti] trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free